Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000670557 | SCV000795420 | uncertain significance | Tay-Sachs disease | 2017-11-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000670557 | SCV001420806 | uncertain significance | Tay-Sachs disease | 2022-09-01 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 410 of the HEXA protein (p.Ala410Val). This variant is present in population databases (rs151251788, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with HEXA-related conditions. ClinVar contains an entry for this variant (Variation ID: 554854). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV000670557 | SCV002085674 | uncertain significance | Tay-Sachs disease | 2018-07-24 | no assertion criteria provided | clinical testing |